Chennai, India

Praven Kumar Luthra

This inventor holds 1 USPTO granted patent. Top assignee: Orchid Chemicals & Pharmaceuticals Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Praven Kumar Luthra. Retrieved from https://idiyas.com/inventor/praven-kumar-luthra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Praven Kumar Luthra: Innovator in Pharmaceutical Chemistry

Introduction

Praven Kumar Luthra is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of important compounds. His work has led to advancements that benefit the medical community and patients alike.

Latest Patents

Luthra holds a patent for a "Method for the preparation of ceftiofur sodium and its intermediates." This innovation is crucial in the production of ceftiofur, an antibiotic used in veterinary medicine. His patent portfolio includes 1 patent, showcasing his focused contributions to pharmaceutical research.

Career Highlights

Luthra is currently employed at Orchid Chemicals & Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his expertise in drug development and contribute to the creation of effective medical solutions.

Collaborations

Throughout his career, Luthra has collaborated with talented professionals, including Pandurang Balwant Deshpande and Sivakumaran Sundaravadivelan. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Praven Kumar Luthra's work exemplifies the impact of dedicated inventors in the pharmaceutical field. His contributions continue to influence the development of essential medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…